- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
All facets of research relating to the emerging discipline of nanobiotechnology—a science that operates at the scale of one-billionth of a meter—will be explored at the second annual Johns Hopkins NanoBio Symposium, May 1 -2, 2008. This year's event will be held at the Johns Hopkins School of Medicine in Baltimore, Md. and is hosted by the Institute for NanoBioTechnology (INBT).
Nearly 400 people attended the inaugural Johns Hopkins NanoBio Symposium. Due to this enthusiastic response, institute leaders chose to expand the 2008 event to two days. "Nanotechnology for Cancer" will be the focus of Thursday's workshop, co-hosted by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. This workshop features short presentations and engaging discussions with several Johns Hopkins faculty experts working in areas relating to nanobiotechnology. It will be held in the Koch Cancer Research Building's Owens Auditorium from 2-5 p.m.
"Advances in nanotechnology coupled with our increasing understanding of cancer make it a uniquely exciting time for a Nanotechnology for Cancer workshop. Nanotechnology promises powerful new tools for both the study and management of this deadly disease," says Kenneth Kinzler, professor of oncology in the School of Medicine, director of the Ludwig Center, and INBT executive committee member.
On Friday, the symposium continues in the Turner Auditorium from 9 a.m.-12:30 p.m., with talks from internationally recognized scholars who specialize in various aspects of nanobiotechnology.
Invited speakers include Donald E. Ingber, M.D., Ph.D., professor or vascular biology from the Harvard Medical School; Andrew D. Maynard, Ph.D., chief science advisor for the Project on Emerging Nanotechnologies at the Woodrow Wilson International Center for Scholars; Paras N. Prasad, Ph.D., director of the Institute for Lasers, Photonics, and Biophotonics at the University at Buffalo; Jeffery A. Schloss, Ph.D., from the National Human Genome Research Institute; and Jennifer L. West, Ph.D., professor of bioengineering at Rice University.
"Symposium attendees will have the opportunity to learn about leading-edge technologies and recent scientific breakthroughs from experts using nanoscale solutions to solve problems in health care and medicine, all at one meeting," says Peter Searson, institute director and professor of materials science and engineering in the Whiting School of Engineering.
The symposium will conclude with a Friday afternoon poster session displaying research from across Johns Hopkins University, as well as from government, and industry. The poster session will be held in Turner Concourse from 2-4:30 p.m.
"This is a terrific opportunity for those engaged in nanobiotechnology related research in an academic or commercial setting to showcase their research together at one of the leading medical institutions in the world," says Denis Wirtz, associate director of INBT and professor of chemical and biomolecular engineering in the Whiting School of Engineering.
All attendees are encouraged to present posters, subject to INBT approval. There is no cost for JHU-affiliated faculty, staff, students and postdoctoral fellows to attend, but online registration is required. Non-affiliated individuals must pay a registration fee, which is listed on the registration form. Registration and guidelines for poster submission are available at http://inbt.jhu.edu. The deadline for poster submissions is April 17, 2008, and the deadline for general registration without a poster is April 24, 2008.
Corporate sponsorships opportunities also are available. For information, contact Mary Spiro at or 410-516-4802.
About Institute for NanoBioTechnology
The Institute for NanoBioTechnology at Johns Hopkins University is revolutionizing health care by bringing together internationally renowned expertise in medicine, engineering, the sciences, and public health to create new knowledge and groundbreaking technologies.
INBT programs in research, education, outreach, and technology transfer are designed to foster the next wave of nanobiotechnology innovation.
Approximately 155 faculty are affiliated with INBT and are also members of the following Johns Hopkins institutions: Krieger School of Arts and Sciences, Whiting School of Engineering, School of Medicine, Bloomberg School of Public Health, and Applied Physics Laboratory.
For more information, please click here
Copyright © Institute for NanoBioTechnologyIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Producing spin-entangled electrons July 2nd, 2015
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Engineering the world’s smallest nanocrystal July 2nd, 2015
Newly-Developed Biosensor in Iran Detects Cocaine Addiction June 23rd, 2015